Belvedere Trading LLC Bluebird Bio, Inc. Transaction History

Belvedere Trading LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$1.32 - $4.83 $2,261 - $8,273	1,713 New	1,713 $2,000
Q4 2022 Feb 14, 2023	SELL	$5.77 - $8.49 $134,844 - $198,411	-23,370 Reduced 22.33%	81,276 $562,000
Q3 2022 Oct 26, 2022	BUY	$3.75 - $7.39 $30,131 - $59,378	8,035 Added 8.32%	104,646 $646,000
Q2 2022 Jul 21, 2022	BUY	$2.94 - $5.23 $184,946 - $329,003	62,907 Added 186.65%	96,611 $463,000
Q1 2022 Apr 20, 2022	BUY	$4.07 - $10.6 $137,175 - $357,262	33,704 New	33,704 $142,000

150

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $708M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.